Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
About Enicepatide (CT-388) Enicepatide is an investigational once-weekly subcutaneous injectable, dual GLP-1/GIP receptor agonist being developed for the treatment of people living with obesity and associated comorbidities including type 2 diabetes (T2D)
To learn more about how health-system pharmacists can impact your overall health, visit yourpharmacist.org
Its a prescription drug thats used to help manage blood sugar levels
Patients should be counseled on strategies to minimize these effects, including eating smaller meals, avoiding high-fat foods, and maintaining adequate hydration
Derivation and validation of ICD-10 codes for identifying incident stroke
The future of equine medicine looks brighter than ever, thanks to innovations like Bepecin and TB-500 nasal spray
US$ 26.50
US$ 23.08
US$ 27.97
US$ 21.56
US$ 24.04
